StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new cash

Cash and short-term investments held at the end of each period.

Protagenic Therapeutics, Inc.new's cash was $565.99K at Jun 30, 2026. For fiscal 2024 it was $79.57K, down 98.0% from the year before. Over ten years it grew -19.7% a year on average. The highest annual figure on record is $10.37M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2024Dec 31, 2024$79.57K-98.0%
FY2023Dec 31, 2023$4.06M-49.2%
FY2022Dec 31, 2022$7.98M-23.1%
FY2021Dec 31, 2021$10.37M+1445.4%
FY2020Dec 31, 2020$671.09K-16.0%
FY2019Dec 31, 2019$798.62K+120.3%
FY2018Dec 31, 2018$362.49K-9.3%
FY2017Dec 31, 2017$399.69K-87.1%
FY2016Dec 31, 2016$3.10M+2969.7%
FY2014Jun 30, 2014$101.00K-85.9%
FY2013Jun 30, 2013$717.00K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ1 2026Jun 30, 2026$565.99K-64.5%
Q4 FY2024CQ4 2024Dec 31, 2024$79.57K-98.0%
Q3 FY2024CQ3 2024Sep 30, 2024$71.40K-98.6%
Q2 FY2024CQ2 2024Jun 30, 2024$713.63K-88.2%
Q1 FY2024CQ1 2024Mar 31, 2024$1.59M-79.2%
Q4 FY2023CQ4 2023Dec 31, 2023$4.06M-49.2%
Q3 FY2023CQ3 2023Sep 30, 2023$5.27M-35.3%
Q2 FY2023CQ2 2023Jun 30, 2023$6.04M-31.9%
Q1 FY2023CQ1 2023Mar 31, 2023$7.65M-21.8%
Q4 FY2022CQ4 2022Dec 31, 2022$7.98M-23.1%
Q3 FY2022CQ3 2022Sep 30, 2022$8.15M-24.9%
Q2 FY2022CQ2 2022Jun 30, 2022$8.87M-25.7%
Q1 FY2022CQ1 2022Mar 31, 2022$9.79M+5005.2%
Q4 FY2021CQ4 2021Dec 31, 2021$10.37M+1445.4%
Q3 FY2021CQ3 2021Sep 30, 2021$10.85M+998.0%
Q2 FY2021CQ2 2021Jun 30, 2021$11.93M+910.2%
Q1 FY2021CQ1 2021Mar 31, 2021$191.67K-74.6%
Q4 FY2020CQ4 2020Dec 31, 2020$671.09K-16.0%
Q3 FY2020CQ3 2020Sep 30, 2020$988.57K+256.4%
Q2 FY2020CQ2 2020Jun 30, 2020$1.18M+247.9%
Q1 FY2020CQ1 2020Mar 31, 2020$753.97K+79.8%
Q4 FY2019CQ4 2019Dec 31, 2019$798.62K+120.3%
Q3 FY2019CQ3 2019Sep 30, 2019$277.39K-35.8%
Q2 FY2019CQ2 2019Jun 30, 2019$339.54K+43.9%
Q1 FY2019CQ1 2019Mar 31, 2019$419.33K+22.2%
Q4 FY2018CQ4 2018Dec 31, 2018$362.49K-9.3%
Q3 FY2018CQ3 2018Sep 30, 2018$431.93K-54.6%
Q2 FY2018CQ2 2018Jun 30, 2018$236.01K-62.4%
Q1 FY2018CQ1 2018Mar 31, 2018$343.29K-87.5%
Q4 FY2017CQ4 2017Dec 31, 2017$399.69K-87.1%
Q3 FY2017CQ3 2017Sep 30, 2017$952.13K-72.7%
Q2 FY2017CQ2 2017Jun 30, 2017$627.83K-83.4%
Q1 FY2017CQ1 2017Mar 31, 2017$2.74M-26.8%
Q4 FY2016CQ4 2016Dec 31, 2016$3.10M+2969.7%
Q3 FY2016CQ3 2016Sep 30, 2016$3.49M+1755.8%
Q2 FY2016CQ2 2016Jun 30, 2016$3.79M+2836.6%
Q1 FY2016CQ1 2016Mar 31, 2016$3.75M–
Q4 FY2014CQ2 2014Jun 30, 2014$101.00K–
Q3 FY2014CQ1 2014Mar 31, 2014$188.00K–
Q2 FY2014CQ4 2013Dec 31, 2013$129.00K–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?